11-94496829-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017704.3(ANKRD49):c.136G>A(p.Val46Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000805 in 1,613,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017704.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD49 | NM_017704.3 | c.136G>A | p.Val46Ile | missense_variant | 2/3 | ENST00000544612.6 | NP_060174.2 | |
ANKRD49 | XM_017017941.2 | c.136G>A | p.Val46Ile | missense_variant | 2/3 | XP_016873430.1 | ||
MRE11 | XM_011542837.3 | c.-105-3923C>T | intron_variant | XP_011541139.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD49 | ENST00000544612.6 | c.136G>A | p.Val46Ile | missense_variant | 2/3 | 1 | NM_017704.3 | ENSP00000440396.1 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251342Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135854
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461812Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727200
GnomAD4 genome AF: 0.000447 AC: 68AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.136G>A (p.V46I) alteration is located in exon 2 (coding exon 1) of the ANKRD49 gene. This alteration results from a G to A substitution at nucleotide position 136, causing the valine (V) at amino acid position 46 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at